LFCR

insider transactions

LIFECORE BIOMEDICAL, INC. \DE\ — buys & sells by directors, officers and 10% owners (SEC Form 4).

30D 90D 1Y

Net shares · 30d

-5.0K

0 buy · 5.0K sell

Net value · 30d

-$1.2M

$0 in · $1.2M out

Sentiment · 30d

Net selling

0% buying · 100% selling

Open-market trades · 30d

0 buy · 5.0K sell

Net buy / sell volume

Tap or hover the chart for daily net volume. Green = net buying, red = net selling.

All transactions

Exercise·M
Jun 12, 26

Matthew E Korenberg KEY

CFO, Treasurer

$0

1.0K sh

Own +1%
Exercise·M
Jun 12, 26

Matthew E Korenberg KEY

CFO, Treasurer

$13.6K

1.0K sh · $13.60

Own New
Sell·S
Jun 11, 26

Jason Aryeh

Director

$1.1M

4.5K sh · $250.00

Own -4%
Sell·S
Jun 10, 26

Jason Aryeh

Director

$125.0K

500 sh · $250.00

Own -0%
Grant·A
Jun 5, 26

Jason Aryeh

Director

$0

2.9K sh

Own New
Grant·A
Jun 5, 26

Jason Aryeh

Director

$0

836 sh

Own +1%
Grant·A
Jun 4, 26

Joshua Schechter

Director

—

25.9K sh

Own +24%
Grant·A
Jun 4, 26

Nelson Obus

Director

—

25.9K sh

Own +19%
Grant·A
Jun 4, 26

Matthew E Korenberg

Director

—

25.9K sh

Own +59%
Grant·A
Jun 4, 26

Paul Harold Johnson

Director

—

25.9K sh

Own +59%
Grant·A
Jun 4, 26

Lovas Katrina Houde

Director

—

25.9K sh

Own +24%
Grant·A
Jun 4, 26

Jason Aryeh

Director

—

25.9K sh

Own +59%
Grant·A
Jun 4, 26

Humberto Calheiros Antunes

Director

—

25.9K sh

Own +55%
Grant·A
Jun 4, 26

Christopher S Kiper / Legion Partners Asset Management, LLC / Legion Partners, L.P. I / Legion Partners, L.P. II / Legion Partners, LLC / Legion Partners Holdings, LLC / Raymond T. White

Director, 10% Owner

—

25.9K sh

Own +33%

Date▾	Insider	Role	Type	Shares	Own Δ	Price	Value
Jun 12, 2026	Matthew E Korenberg KEY	CFO, Treasurer	Exercise M	1.0K	+1%	—	$0
Jun 12, 2026	Matthew E Korenberg KEY	CFO, Treasurer	Exercise M	1.0K	New	$13.60	$13.6K
Jun 11, 2026	Jason Aryeh	Director	Sell S	4.5K	-4%	$250.00	$1.1M
Jun 10, 2026	Jason Aryeh	Director	Sell S	500	-0%	$250.00	$125.0K
Jun 5, 2026	Jason Aryeh	Director	Grant A	2.9K	New	—	$0
Jun 5, 2026	Jason Aryeh	Director	Grant A	836	+1%	—	$0
Jun 4, 2026	Joshua Schechter	Director	Grant A	25.9K	+24%	—	—
Jun 4, 2026	Nelson Obus	Director	Grant A	25.9K	+19%	—	—
Jun 4, 2026	Matthew E Korenberg	Director	Grant A	25.9K	+59%	—	—
Jun 4, 2026	Paul Harold Johnson	Director	Grant A	25.9K	+59%	—	—
Jun 4, 2026	Lovas Katrina Houde	Director	Grant A	25.9K	+24%	—	—
Jun 4, 2026	Jason Aryeh	Director	Grant A	25.9K	+59%	—	—
Jun 4, 2026	Humberto Calheiros Antunes	Director	Grant A	25.9K	+55%	—	—
Jun 4, 2026	Christopher S Kiper / Legion Partners Asset Management, LLC / Legion Partners, L.P. I / Legion Partners, L.P. II / Legion Partners, LLC / Legion Partners Holdings, LLC / Raymond T. White	Director, 10% Owner	Grant A	25.9K	+33%	—	—

About LFCR insider trading

This page tracks insider transactions for LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.